Why Medicover stock moves
Medicover rose slightly without a company-news explanation.
Written after the close on ·
Why today
16,876 news analyzed todayMedicover rose slightly without a company-news explanation.
In the last session Medicover rose slightly while OMX Stockholm 30 fell clearly, so it moved against the market.
The move was ordinary for Medicover, within its usual daily range.
Over the last five trading days the stock fell sharply while the market was roughly flat.
Its third-quarter report came out before that session.
Today's move of +0.95% was 1.1 times a normal day's 0.9%. OMX Stockholm 30 moved −1.01% on the same day.
Medicover +0.95%OMX Stockholm 30 −1.01%Against the market
What analysts expect, and how often they have been right
Analysts’ estimates for Medicover.
Medicover earned more than expected in 7 out of 8 reports.
For comparison, about 46% of reports from Nordic companies beat the estimate in the last three years.
The share moved in the same direction as the earnings surprise in 6 out of 8 reports with a measured move, against about 63% of reports from Nordic companies.
Ratings
Price targets
Latest price 267.00 SEK
Earnings against expectations, and the share’s reaction
Expected EPSAbove estimateBelow estimateAs expectedEUR
Next reported quarter: expected earnings per share of 0.15 EUR (February 10). For the current fiscal year, expected earnings per share changed from 0.69 EUR three months ago to 0.71 EUR now. 2026 estimate: 0.71 EUR. 2027 estimate: 0.91 EUR. People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor. September 25: Sell about 10 m SEK. September 11: Buy about 235 thousand SEK. August 12: Buy about 220 thousand SEK. August 10: Sell about 23 m SEK. August 7: Sell about 2.7 m SEK.
What the key figures say about Medicover
The figures connect what Medicover earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: 0.08 EUR–0.51 EUR. Peers: COMPASS Pathways -$2.34, Terveystalo 0.45 EUR, Humana 3.69 SEK. 2026 estimate: 0.71 EUR (0.71 EUR–0.71 EUR). 2027 estimate: 0.91 EUR (0.80 EUR–1.09 EUR).
What the company sold during the year.
2022–2025: 1.5 bn EUR–2.4 bn EUR. Peers: Terveystalo 1.2 bn EUR, Humana 10.1 bn SEK. 2026 estimate: 2.5 bn EUR (2.4 bn EUR–2.6 bn EUR). 2027 estimate: 2.6 bn EUR (2.5 bn EUR–2.6 bn EUR).
The percentage of revenue left after the costs of running the business.
2022–2025: 3.5%–6.5%. Peers: Terveystalo 8.0%, Humana 4.3%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: 2.5%–14.5%. Peers: COMPASS Pathways −296.5%, Terveystalo 10.4%, Humana 5.4%.
Money paid to shareholders per share, summed by calendar year.
2021–2025: 0.77 SEK–1.65 SEK.
The ordinary yearly dividend as a percentage of the share price.
2022–2025: 0.7%–0.9%. Peers: COMPASS Pathways 0.0%, Terveystalo 10.3%, Humana 0.0%.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: 3.59–4.17. Peers: Terveystalo 4.22, Humana 7.64.
More key figures
Cash left after investments, divided by the number of shares.
2022–2025: 0.20 EUR–1.23 EUR. Peers: COMPASS Pathways -$1.25, Terveystalo 0.73 EUR, Humana 16.56 SEK.
The percentage of assets financed by shareholders’ equity.
2022–2025: 21.7%–25.8%.
The dividend explained
A dividend is money paid to shareholders. Medicover paid 2.21 SEK per share in the twelve months through November 6, 2026.
2021: 0.77 SEK2022: 1.32 SEK2023: 1.32 SEK2024: 1.32 SEK2025: 1.65 SEK2026 so far: 2.21 SEK
What followed similar falls?
Including reinvested dividends, Medicover fell 5.8% over the latest five trading days. Since May 23, 2017, falls at least this large were followed by a higher value 21 trading days later in 17 out of 38 non-overlapping periods. The median was −0.6%, against +1.1% for an ordinary 21-day period, which ended higher 55 times in 100.
Such a fall has not said much about the next month.
−0.6% · 17/38
What to watch next, and why
The earnings report shows how Medicover's revenue and profit have changed.
- Earnings report
The earnings report shows how Medicover's revenue and profit have changed.
Add to calendar
More about Medicover
Insider trades
People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor.
- Staffan Ternström, senior executiveSellabout 10 m SEK
- Marcus Menzer, senior executiveBuyabout 235 thousand SEK
- Lukasz Krause, senior executiveBuyabout 220 thousand SEK
- Fredrik Rågmark, board memberSellabout 23 m SEK
- Jenny Kristina Brandt, senior executiveSellabout 2.7 m SEK
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 15 report days Medicover usually moved about 5.8%. On a normal day it moves 0.9%.
−0.72% +2.95% +8.81% +8.15%
10,000 SEK in Medicover bought on May 23, 2017 is worth 40,900 SEK today, with dividends reinvested.
The same amount in OMX Stockholm 30 with dividends would have become 25,900 SEK.
What would 10,000 SEK in Medicover be worth today? →
What would 10,000 SEK in Medicover be worth today?
40,900 SEK
with dividends reinvested, bought on May 23, 2017. The same amount in OMX Stockholm 30 with dividends would have become 25,900 SEK.
At worst it was worth 8,970 SEK (September 19, 2017).
The five biggest days of the journey
· +23.3% · the whole market rose 1.3% the same day · report day
· +18.2% · the whole market rose 4.5% the same day
· −15.9% · the whole market fell 4.9% the same day
· −15.2% · the whole market fell 10.6% the same day
· +12.7% · the whole market rose 0.4% the same day
Earlier days
−5.82% market −0.11% Medicover fell sharply over the week while the Stockholm market was roughly flat. Read →
Medicover fell sharply over the week while the Stockholm market was roughly flat.
The drop came right after the November 4 quarterly report, which showed revenue growth but a slightly weaker-than-hoped profit per share.
On November 5, several analysts changed their price targets, the share price they see as fair: Nordea cut its target while DNB Carnegie raised its target and kept its buy rating.
The last session saw a small rise against a clearly weaker market, with trading well above normal.
−3.47% market −0.32% Medicover fell after ABG flagged reimbursement risk ahead. Read →
Medicover fell after ABG flagged reimbursement risk ahead.
It fell sharply over the last five trading days, while OMX Stockholm 30 rose slightly.
The ABG comment that reimbursement changes ahead could weigh on results is the reason.
Yesterday's quarterly report was about in line with expectations, with revenue up 6.0% and operating profit up 22.0%.
The next earnings report is due on Wednesday 10 February 2027.
Learn more · Why do stocks go up and down?